Label-free and sensitive detection of N6-methyladenosine demethylase activity in crude cell extracts and clinical cancer tissues based on demethylation-triggered exponential signal amplification.

Cancer diagnosis Fluorescent detection RNA demethylase Signal amplification

Journal

Analytica chimica acta
ISSN: 1873-4324
Titre abrégé: Anal Chim Acta
Pays: Netherlands
ID NLM: 0370534

Informations de publication

Date de publication:
16 Oct 2023
Historique:
received: 09 06 2023
revised: 31 07 2023
accepted: 09 08 2023
medline: 18 9 2023
pubmed: 15 9 2023
entrez: 14 9 2023
Statut: ppublish

Résumé

The m6A demethylase catalyzes the removal of m6A modification to establish proper RNA methylation patterns, and it has emerged as a promising disease biomarker and a therapeutic target. The reported m6A demethylase assays often suffer from tedious producers, expensive reagents, radioactive risk, limited sensitivity, and poor specificity. Herein, we develop a simple, selective, label-free, and highly sensitive fluorescent biosensor for m6A demethylase assay based on demethylation-triggered exponential signal amplification. In this biosensor, m6A demethylase-catalyzed demethylation can protect the circular DNA from the digestion by DpnI, subsequently triggering hyperbranched rolling circle amplification to achieve exponential signal amplification for producing abundant ssDNA and dsDNA products. The amplified DNA signal can be sensitively and simply detected by SYBR Gold in a label-free manner. This biosensor avoids any antibodies, washing/separation procedures, and fluorophore-/quencher-labeled probes, great simplifying the assay procedures and reducing the assay cost. Moreover, this biosensor achieves good specificity and excellent sensitivity with a detection limit of 1.2 fg/μL, which is superior to conventional ELISA (36.3 pg/μL). Especially, this biosensor enables direct monitoring of m6A demethylase activity in crude cell extracts with high accuracy, and it can be further applied for the screening of m6A demethylase inhibitor, measurement of m6A demethylase activity in different cell lines, and discrimination of m6A demethylase level in clinical cancer and healthy tissues, providing a facile and robust platform for RNA methylation-related biomedical research, disease diagnosis, and drug discovery.

Identifiants

pubmed: 37709449
pii: S0003-2670(23)00926-1
doi: 10.1016/j.aca.2023.341705
pii:
doi:

Substances chimiques

Cell Extracts 0
Adenosine K72T3FS567
Fluorescent Dyes 0
RNA 63231-63-0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

341705

Informations de copyright

Copyright © 2023. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Na Li (N)

School of Chemistry and Chemical Engineering, Southeast University, Nanjing, 211189, China.

Lingfei Zhang (L)

Center for Disease Control and Prevention of Weihai City, Weihai, 264200, China.

Hao Liu (H)

School of Food and Biological Engineering, Shaanxi University of Science and Technology, Xi'an, 710021, China.

Qinfeng Xu (Q)

School of Food and Biological Engineering, Shaanxi University of Science and Technology, Xi'an, 710021, China.

Fei Ma (F)

School of Chemistry and Chemical Engineering, Southeast University, Nanjing, 211189, China. Electronic address: fei@seu.edu.cn.

Chun-Yang Zhang (CY)

School of Chemistry and Chemical Engineering, Southeast University, Nanjing, 211189, China. Electronic address: zhangcy@seu.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH